O'CONNOR DONAL received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/17/2026ACC: 0001625377-26-000004
+19.41K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
19.41K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+6.01K
Price / share
—
Trade value
—
% of position
8.1%
6/12/2026
74.20K→80.21K
Total
Net shares
+6.01K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/12/2026 | A · Award | +6.01K | — | — | 8.1% | 74.20K | 80.21K |
| Total | +6.01K | $0.00 | ||||||
Derivative Transactions1
Share Option (Right to Buy)
Direct
Converts to
Ordinary Shares
13.40K shares
Shares
+13.40K
Strike price
16.64
Held after
13.40K
Exercisable
—
6/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy) Direct | Ordinary Shares13.40K shares | 6/12/2026 | A · Award | +13.40K | 16.64 | — | 13.40K |